Interaction between pharmaceutical company representatives and healthcare professionals should take place within legal framework
25 April 2012, Moscow. – The Institute of Legislation and Comparative Law under the Government of the Russian Federation presented Legal Opinion on the topic ‘Legal Aspects of Interaction between Pharmaceutical Company Representatives and Healthcare Professionals’. This Legal Opinion was prepared with the support of the Association of International Pharmaceutical Manufacturers (AIPM).

AIPM recognized as the most influential non-profit association in the Russian pharmaceutical market in 2011
On March 19, 2012, Pharmatsevtichenskiy vestnik (Pharmaceutical bulletin) newspaper and “Pharmexpert” Market Research Centre announced the most influential entities of the Russian pharmaceutical market in 2011. The annual review, which has been conducted more than 10 years, surveys independent market experts across various areas to rank influence in the Russian healthcare industry. Based on the answers provided by peers and industry experts, AIPM was named the Most Influential Non-Profit and Public Association by a wide margin.

AIPM IN PARTNERSHIP WITH EURORDIS SUPPORTS INITIATIVES
All over the world February, 29 was marked as International Rare Disease Day - when the organizations active in the field of rare diseases and their partners join forces to raise awareness of society on problems of millions of people living with orphan diseases. Association of International Pharmaceutical Manufacturers (AIPM) partners with the international non-governmental patient-driven alliance EURORDIS and contributes to the communication to the Russian patients, doctors, and other stakeholders with the Russian version of web resource www.eurordis.org/ru

Russian Pharmaceutical Forum
On 22nd – 24th May 2012 Adam Smith Institute in Saint-Petersburg hosts the 18th International Russian Pharmaceutical Forum.

State regulation and Russian pharmaceutical industry in 2012: Running the Dialog
The 4th Conference of Associations will be held on 5 April 2012 in Borodino Hotel (Rusakovskaya Street, 13). Participants will focus on integration of Russia in global institutions and effects it will have on the pharmaceutical industry: the EU experience and the Customs Union issues.

CIS Pharmaceutical Forum 2012
CIS Pharmaceutical Forum 2012 of Adam Smith Conferences will be taking place on 14-16 February 2012 at the Renaissance Moscow Monarch Centre Hotel. Event website http://www.adamsmithconferences.com/HR19AIPMe The Association of International Pharmaceutical Manufacturers supports this Forum and you can apply for 15% discount*! See below for details

7th International Conference “Pharmaceutical Business in Russia – 2012: period of change”
Dear Colleagues, 7th International Conference “Pharmaceutical Business in Russia – 2012: period of change” will take place on 6-7 February 2012 in Moscow, Swissotel Krasnye Holmy organized by Infor-Media Russia and supported by the Association.

AIPM CONTRIBUTES TO COUNTERACTION TO THE COUNTERFEITING OF MEDICAL PRODUCTS
MOSCOW, November 1, 2011 The Association of International Pharmaceutical Manufacturers (AIPM) actively participates in the work of “The Council of Europe Convention on Counterfeiting of Medical Products and Similar Crimes Involving Threats to Public Health (Medicrime Convention)”, High Level International Conference held in Moscow on October 26 - 28, 2011.

Innovative Drug R&D in Russia Forum of Adam Smith Conferences will take place on 21-22 November in Moscow
The Forum’s 2-day programme will address all the issues that will define innovative drug research and development in the coming months and years. The discussions will cover government strategies and policies, innovative initiatives by Russian and foreign companies, new investment projects, sources of finance, as well as cluster policy development. Event website http://www.adamsmithconferences.com/hr18aipmwe

MEDICAL REPRESENTATIVES ACTIVITIES SHALL BE REGULATED RATHER THAN BANNED
May 17, 2011, Saint-Petersburg. Association of International Pharmaceutical Manufacturers (AIPM) believes that the introduction of the proposed wording of the Article 69 of the Federal law draft “On bases of health protection of citizens of the Russian Federation” can cause serious damage to Russian healthcare. This opinion was expressed during the Russian Pharmaceutical Forum of Adam Smith Institute.

RUSSIANS EVIDENTLY OVERESTIMATE THEIR STATE OF HEALTH AS GOOD AND FAIR
The results of AIPM research show an insufficient level of diagnosis and low awareness of their personal health.

PRESS INVITATION
Time: Tuesday, 26th April, 2011, from 11.00 to 12.30 Place: RIA Novosti Press-Center, Conference Hall ¹1, 4 Zubovsky Bulvar, Moscow

DESPITE CONCERNS ABOUT THEIR HEATLH, MOST RUSSIANS BELIEVE THAT LEADING A HEALTHY LIFESTYLE IS DIFFICULT, EXPENSIVE AND TIME-CONSUMING.
AIPM conducted a research devoted to the attitude of Russians to personal health

Russian Pharmaceutical Forum
On 17-19 May, Adam Smith Institute in Saint-Petersburg hosts the 17th International Russian Pharmaceutical Forum

Eisai, Galderma, Macleods and Takeda – AIPM Members
Eisai, Galderma, Macleods and Takeda were admitted to membership in the Association of International Pharmaceutical Manufacturers (AIPM) at a General Meeting of Members of the Association.

Harmonization of Drug Circulation in CIS Member Countries Discussed in Moscow
On March 18, 2011, Moscow hosted the International Economic Forum of the CIS Member States titled “Twenty Years Together: Cooperation Experience and Prospects”. The Association of International Pharmaceutical Manufacturers (AIPM) was an active contributor to the Forum

18th Annual Regulatory Affairs in Central and Eastern Europe Conference
18th Annual Regulatory Affairs in Central and Eastern Europe Conference. 12 April 2011 - 13 April 2011, Angelo Hotel Prague.

Adam Smith Conferences’ CIS Pharmaceutical Forum
Adam Smith Conferences’ CIS Pharmaceutical Forum will be taking place in Moscow on 15-17 February

Novartis AG is about to build a plant in Russia
Novartis AG is planning to build a 2-billion-units plant in the territory of a pharmaceutical cluster in Saint-Petersburg. The level of investment will make up 500 billion dollars within the next 5 years.

National drug policy forum to take place in Moscow
The National drug policy forum has been held in Moscow on December 10. Tatiana Golikova, Minister of Healthcare and Social Development, has presented the main legislation initiatives carried out in this field: the Public health protection law, the Biomedical technologies law, the Compulsory medical organizations' responsibility law. Mrs Golikova has also told about the Compulsory medical insurance law and the Regional health care programs which would cost about 460 billion dollars to the government.